Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Prior clinical trial data suggests the presence of baseline Q-waves in the distribution of STEMI surpasses time of symptom onset as a prognostic marker of adverse outcomes. Whether the choice of reperfusion strategy mitigates these risks remains unclear. Moreover, those without baseline Q-waves are more likely to have ‘fresh’ thrombus whereby fibrinolysis with a pharmacoinvasive (PI) strategy may be more effective in achieving timely reperfusion.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
